Kaya Limited 23rd AGM on August 7, 2026: Annual Report and Key Agenda Items
Kaya Limited has convened its 23rd Annual General Meeting for August 7, 2026 via video conferencing, with the Annual Report for FY2025-26 dispatched to members on July 15, 2026. The AGM agenda covers adoption of financial statements, re-appointment of Mr. Rajendra Mariwala as Non-Executive Director, and a Special Resolution for re-appointment of Ms. Vasuta Agarwal as Independent Director for a second five-year term from August 3, 2026 to August 2, 2031. FY26 consolidated revenue from operations was ₹22,247.55 lakh, with a net loss of ₹9,617.29 lakh from continuing operations, compared to a profit of ₹8,367.53 lakh in the prior year which included gains from discontinued Middle East operations.

*this image is generated using AI for illustrative purposes only.
Kaya Limited has announced that its 23rd Annual General Meeting will be held on Friday, August 7, 2026 at 9:30 a.m. IST through Video Conferencing/Other Audio Visual Means. The notice, filed with BSE Limited and the National Stock Exchange of India Limited under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was signed by Brijesh Goyal, Chief Financial Officer, and dispatched on July 15, 2026. The Annual Report for the financial year 2025-26 has been sent electronically to members whose email addresses are registered with the Company, Registrar and Transfer Agent, or Depositories.
AGM Meeting Details
The meeting will be conducted entirely via video conferencing, with members encouraged to participate through the NSDL e-Voting system. The AGM shall be deemed to be held at the Registered Office of the Company at 23/C, Mahal Industrial Estate, Mahakali Caves Road, Near Paperbox Lane, Andheri (East), Mumbai – 400093. The cut-off date for voting rights is July 31, 2026. Remote e-voting commences on Tuesday, August 4, 2026 at 9:00 a.m. IST and ends on Thursday, August 6, 2026 at 5:00 p.m.
| Parameter: | Details |
|---|---|
| Event: | 23rd Annual General Meeting |
| Date: | August 7, 2026 |
| Time: | 9:30 a.m. IST |
| Mode: | Video Conferencing / OAVM |
| Notice Dispatch Date: | July 15, 2026 |
| Cut-off Date for Voting: | July 31, 2026 |
| Remote E-Voting Period: | August 4–6, 2026 |
AGM Agenda
The ordinary business includes adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors. The meeting will also consider the re-appointment of Mr. Rajendra Mariwala (DIN: 00007246), Non-Executive Director, who retires by rotation and is eligible for re-appointment.
Under special business, members will vote on the re-appointment of Ms. Vasuta Agarwal (DIN: 07480674) as an Independent Director for a second term of five consecutive years commencing from August 3, 2026 to August 2, 2031 (both days inclusive). Ms. Agarwal was first appointed as an Independent Director at the 18th Annual General Meeting held on September 21, 2021, for a period of five years commencing from August 3, 2021 up to August 2, 2026. The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, appointed her as an Additional Director (Independent) with effect from August 3, 2026, and has recommended her re-appointment by Special Resolution.
Director Profiles for Re-appointment
The following table summarises key information on the directors seeking re-appointment, as required under Regulation 36(3) of the SEBI Listing Regulations:
| Particulars: | Mr. Rajendra Mariwala | Ms. Vasuta Agarwal |
|---|---|---|
| Designation: | Non-Executive Director | Independent Director |
| DIN: | 00007246 | 07480674 |
| Age (in years): | 63 | 42 |
| Date of First Appointment: | November 1, 2011 | August 3, 2021 |
| Qualification: | Master's in Chemical Engineering | PGDM from IIM Bangalore; B.E. from BITS Pilani |
| Experience: | More than 30 years | 19 Years |
| Proposed Term: | Non-Executive, liable to retire by rotation | Independent Director, not liable to retire by rotation, for five years from August 3, 2026 to August 2, 2031 |
| Sitting Fees Last Drawn (₹): | 7,50,000 | 7,50,000 |
| Shareholding in Company: | 1,86,924 equity shares of ₹10/- each | 0 |
| Board Meetings Attended (FY 2025-26): | 5 of 6 | 6 of 6 |
FY26 Financial Performance
Kaya Limited reported its financial results for the financial year ended March 31, 2026. On a consolidated basis, the company registered total revenue from operations of ₹22,247.55 lakh, an increase of approximately 2.4% over the previous year. A consolidated net loss of ₹9,617.29 lakh was reported for the financial year under review, compared to a consolidated profit of ₹8,367.53 lakh in the previous financial year. The Board of Directors has not recommended any dividend for the financial year ended March 31, 2026.
The following table presents key standalone and consolidated financial highlights:
| Particulars (₹ in lakhs): | Standalone FY26 | Standalone FY25 | Consolidated FY26 | Consolidated FY25 |
|---|---|---|---|---|
| Revenue from Operations: | 22,247.55 | 21,742.30 | 22,247.55 | 21,716.83 |
| Other Income: | 868.20 | 1,705.40 | 869.33 | 1,705.40 |
| Total Income: | 23,115.75 | 23,447.70 | 23,116.89 | 23,422.23 |
| Total Expenses: | 32,583.77 | 26,098.76 | 32,589.10 | 26,759.00 |
| Loss Before Tax: | (9,613.12) | (2,651.06) | (9,617.29) | (3,336.77) |
| Net Loss (Continuing Operations): | (9,613.12) | (2,651.06) | (9,617.29) | (3,336.77) |
| Profit/(Loss) from Discontinued Operations: | — | — | — | 11,704.30 |
| Net Loss/Profit for the Period: | (9,613.12) | (2,651.06) | (9,617.29) | 8,367.53 |
On a standalone basis, net revenue grew 2% to ₹22,248 lakh. EBITDA stood at ₹(1,365) lakh (-6% of net revenue) compared to ₹2,523 lakh (12% of net revenue) in FY25. Depreciation and amortisation expenses grew by 17% to ₹4,401 lakh. An impairment loss of ₹1,177 lakh on Property, Plant and Equipment was recognised during the year. Other income in FY26 was ₹868 lakh compared to ₹1,705 lakh in FY25. Total Comprehensive Loss was ₹(9,637) lakh in FY26 compared to ₹(2,690) lakh in FY25. Fixed Assets (net of depreciation) increased by ₹1,512 lakh during FY26 from ₹5,638 lakh in FY25 to ₹7,150 lakh in FY26.
Business Operations and Share Capital
Kaya Limited operates a network of 80+ clinics across 26 cities and 15 states, supported by 120+ dermatologists and over 600 service lines. Services contributed 84% of clinic business in FY26, with growth driven by anti-ageing, acne and scars, pigmentation management, hair care, and body contouring categories. Products contributed 16% to clinic collections, with product revenue from Kaya Clinic at ₹3,556 lakh in FY26 and 75+ product offerings. The company reported collections of ₹25,533 lakh in FY26 compared to ₹25,016 lakh in FY25.
During the year, the Company issued 20,90,068 equity shares on August 12, 2025 to Axana Estates LLP pursuant to a Preferential Issue at a price of ₹358.84 per equity share, aggregating to ₹75,00,00,001. The paid-up equity share capital as on March 31, 2026 stands at ₹15,18,76,090 divided into 1,51,87,609 equity shares of ₹10/- each. Promoters held 51.43% of the total shareholding as at March 31, 2026.
Key Corporate Developments
The Scrutinizer for the AGM voting process is Mr. Sitansh Magia, Partner (Membership No. A15169 | CP No. 18972) of M/s. Magia Halwai & Associates, Practicing Company Secretary. Voting results, along with the Scrutinizer's report, will be placed on the Company's website www.kaya.in and communicated to BSE Limited and National Stock Exchange of India Limited. Members with queries may contact the Company at kayainvestorrelations@kayaindia.net on or before 5:00 p.m. on Friday, July 31, 2026.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE587G01015/e3fa2f84-1736-4974-8812-39d241a4eae9.pdf
Historical Stock Returns for Kaya
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.26% | -1.10% | -7.11% | -37.55% | -42.38% | -55.44% |
What specific strategic measures will management implement to reverse the consolidated net loss of ₹9,617.29 lakh reported in FY26?
How does the company plan to optimize the 80+ clinic network and address the impairment loss of ₹1,177 lakh on Property, Plant and Equipment?
Will the recent preferential issue of equity shares to Axana Estates LLP lead to changes in the company's capital allocation or expansion strategy?































